Making an impact with nanocomposites

Nanoclays can improve the performance of injection-molded polypropylene components likely to be subjected to impact in servic

Surface property effects of compounding a nanoclay masterbatch in PP injection moulding

Indicado para o prémio de melhor artigo mais inovador.The interest on the use of nanofillers in injection mouldings has been going on for more than a decade but a real breakthrough has not been achieved yet, especially in that mechanical properties are concerned. The nucleating effect of nanoclays in semicrystalline polymers suggests that surface effects may result interesting especially during processing. This paper includes some information on the surface properties of an injection moulding grade of polypropylene mixed with a commercial masterbatch of PP and 50% of organoclay. They were moulded as plates for testing in a prototype device for determining the coefficient of friction in as-moulding conditions. The surface was also characterised by depth sensing indentation tests. The through thickness microstructures of the mouldings were assessed by optical microscopy and differential scanning calorimetry, while surface morphology was assessed by X-ray diffraction. It was observed that independently of MB content, its addition caused a slight increase in elastic modulus and hardness in the skin layer.The friction properties directly associable to the product performance showed a slight improvement in terms of the dynamic friction coefficient. Conversely the static friction coefficient that is relevant in processing was no affected by the presence of the nanoclay

Impact behavior of injected PP/nanoclay parts

This work attempts to contribute to bridge the gap between scientific challenges and industrial stakes regarding PP/nanoclay composites. Pieces of nanocomposites were obtained by direct injection of commercial PP mixed with a commercial MB of PP with 50% of organoclay, with a double-gated hot runner mould, which produced mouldings with a weld line. The moulding microstructure was assessed by POM and XRD, while the distribution and exfoliation grade of clay was evaluated by TEM and XRD. The typical skin-core structure was found, with a skin thickness wider in bulk than in weld line zones. Regarding clay platelets mostly intercalated structures were seen. The impact properties at room temperature were assessed by means of tensile and biaxial tests. Properties were monitored at different sites of the mouldings. At the weld line zone less energy was consumed under tensile conditions and exhibited higher apparent impact toughness under biaxial conditions than the bulk zone. Visual inspection of biaxially impacted samples showed that the orientation of polymer molecules and clay platelets induced by melt flow prevailed, and the weld line was not the determinant of the toughness of the mouldings. An optimum in impact performance was found for moulding with 3% of clay, since at larger clay contents platelets agglomerated and acted as stress raisers

Uni- and biaxial impact behavior of double-gated nanoclay-reinforced polypropylene injection moldings

Polypopylene/nanoclay three-dimensional parts were produced without intermediate steps by direct injection molding to explore the influence of flow features and nanoclay incorporation in their impact performance. The nanocomposite was obtained by direct compounding of commercial PP with nanoclay masterbatch. The as-molded morphology was analyzed by X-ray and TEM analyses in terms of skin-core structure and nanoclay particle dispersion. The nanoclay particles induced the reduction of b-form spherulites, a known toughener. The impact behavior was assessed in tensile and biaxial modes. The PP nanocomposite molding toughness was practically unaffected by the processing melt temperature and flow rate. Conversely the nanoclay presence is influent in the impact performance. Under biaxial stress impact, the regions close to weld lines are tougher than the bulk and the fracture develops with main crack paths along the flow direction and the weld line. Cracking along the weld line results from less macromolecular interpenetration and chain entanglement, and unfavorable nanoparticle orientation. It seems that a failure mechanism which involves nanoclay delamination and multiple matrix crazing explains the toughening of PP in the directions where the nanoparticle orientation with respect to loading is adequate.Contract grant sponsors: CONICET, ANPCyT from Argentina, MINCyT (Argentina) - FCT (Portugal), Universities Nacional de Mar del Plata and Minho

DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation

Hematopoietic stem cells give rise to all blood cells in a differentiation process that involves widespread epigenome remodeling. Here we present genome-wide reference maps of the associated DNA methylation dynamics. We used a meta-epigenomic approach that combines DNA methylation profiles across many small pools of cells and performed single-cell methylome sequencing to assess cell-to-cell heterogeneity. The resulting dataset identified characteristic differences between HSCs derived from fetal liver, cord blood, bone marrow, and peripheral blood. We also observed lineage-specific DNA methylation between myeloid and lymphoid progenitors, characterized immature multi-lymphoid progenitors, and detected progressive DNA methylation differences in maturing megakaryocytes. We linked these patterns to gene expression, histone modifications, and chromatin accessibility, and we used machine learning to derive a model of human hematopoietic differentiation directly from DNA methylation data. Our results contribute to a better understanding of human hematopoietic stem cell differentiation and provide a framework for studying blood-linked diseases.This work was funded by the BLUEPRINT project (European Union’s Seventh Framework Programme grant 282510), the NIHR Cambridge Biomedical Research Centre, and the Austrian Academy of Sciences. F.A.C. is supported by a Medical Research Council Clinical Training Fellowship (grant MR/K024043/1). F.H. is supported by a postdoctoral fellowship of the German Research Council (DFG; grant HA 7723/1-1). J.K. is supported by a DOC Fellowship of the Austrian Academy of Sciences. W.H.O. is supported by the NIHR, BHF (grants PG-0310-1002 and RG/09/12/28096), and NHS Blood and Transplant. E.L. is supported by a Wellcome Trust Sir Henry Dale Fellowship (grant 107630/Z/15/Z) and core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. M. Frontini is supported by the BHF Cambridge Centre of Excellence (grant RE/13/6/30180). C.B. is supported by a New Frontiers Group award of the Austrian Academy of Sciences and by a European Research Council (ERC) Starting Grant (European Union’s Horizon 2020 research and innovation program; grant 679146)

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses

Our aim was to study the activity and toxicity of the gemcitabine plus vinorelbine (Gem Vin) combination and to identify the optimal dose. Previously untreated patients aged < 70 years, with stage IV or IIIb (not candidates for radiotherapy) non-small cell lung cancer were eligible. Studied dose-levels of Gem Vin, administered on days 1 and 8 every 3 weeks, were (mg m–2): level I = 1000/25; level II = 1200/25; level III = 1000/30; level IV = 1200/30. A feasibility study was performed at each dose-level, followed by a single-stage phase II study. Dose-level IV was unfeasible because of grade 4 neutropenia. Overall, out of 126 patients enrolled in phase II studies, there were one complete and 32 partial responses (response rate 26%: 95% CI 18–34%). Response rates were 27.9%, 21.4% and 29.3% at levels I, II and III, respectively. The treatment was well tolerated. Toxicity was less frequent and severe at level I. Overall median survival was 33 weeks (95% CI 28–40). Descriptive quality of life analysis showed that patients with a worse baseline global health status score tended to drop out of the study earlier than those with a better score. Gem Vin is feasible at different doses. It is sufficiently active and well tolerated. A phase III study to compare the effect on quality of life of Gem Vin (level I) vs cisplatin-based chemotherapy is ongoing. © 2000 Cancer Research Campaig

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

Pain is a highly distressing symptom for patients with advanced cancer. WHO analgesic ladder is widely accepted as a guideline for its treatment. Our aim was to describe pain prevalence among patients diagnosed with advanced non-small-cell lung cancer (NSCLC), impact of pain on quality of life (QoL) and adequacy of pain management. Data of 1021 Italian patients enrolled in three randomised trials of chemotherapy for NSCLC were pooled. QoL was assessed by EORTC QLQ-C30 and LC-13. Analgesic consumption during the 3 weeks following QoL assessment was recorded. Adequacy of pain management was evaluated by the Pain Management Index (PMI). Some pain was reported by 74% of patients (42% mild, 24% moderate and 7% severe); 50% stated pain was affecting daily activities (30% a little, 16% quite a bit, 3% very much). Bone metastases strongly affected presence of pain. Mean global QoL linearly decreased from 64.9 to 36.4 from patients without pain to those with severe pain (P<0.001). According to PMI, 616 out of 752 patients reporting pain (82%) received inadequate analgesic treatment. Bone metastases were associated with improved adequacy and worst pain with reduced adequacy at multivariate analysis. In conclusion, pain is common in patients with advanced NSCLC, significantly affects QoL, and is frequently undertreated. We recommend that: (i). pain self-assessment should be part of oncological clinical practice; (ii). pain control should be a primary goal in clinical practice and in clinical trials; (iii). physicians should receive more training in pain management; (iv). analgesic treatment deserves greater attention in protocols of anticancer treatment